A critical reappraisal of off-label indications for topical photodynamic therapy with aminolevulinic acid and methylaminolevulinate

Reviews on Recent Clinical Trials

Volumn 5, Issue 2, 2010, Pages 112-116

  Piergiacomo, Calzavara Pinton ^a   Mariachiara, Arisi ^a   Elena, Sereni ^a   Bernhard, Ortel ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

ALA MAL photodynamic therapy; Photodynamic therapy; Skin cancer

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER;

ACANTHOMA; ACNE; ACNE VULGARIS; ACTINIC KERATOSIS; ACTINIC POROKERATOSIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; BURNING SENSATION; CONDYLOMA ACUMINATUM; CONFLUENT AND RETICULATED PAPILLOMATOSIS; CUTANEOUS T CELL LYMPHOMA; DARIER DISEASE; DISCOID LUPUS ERYTHEMATOSUS; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; EPIDERMODYSPLASIA VERRUCIFORMIS; ERYTHEMA; ERYTHROPLASIA; FOLLICULITIS; GRANULOMA ANNULARE; HAILEY HAILEY DISEASE; HAIR FOLLICLE; HIRSUTISM; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; INVASIVE CARCINOMA; KERATINIZATION; KERATINOCYTE; KERATOACANTHOMA; KERATODERMA; LEG ULCER; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; MELANOMA; MOLLUSCUM CONTAGIOSUM; MUCINOSIS; MYCOSIS FUNGOIDES; NECROBIOSIS LIPOIDICA; NEPHROGENIC SYSTEMIC FIBROSIS; NONHUMAN; OFF LABEL DRUG USE; ONYCHOMYCOSIS; PAGET SKIN DISEASE; PHOTOAGING; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PSEUDOLYMPHOMA; PSORIASIS; RADIATION DERMATITIS; RASH; REJUVENATION; ROSACEA; SARCOIDOSIS; SCAR FORMATION; SCLERODERMA; SEBACEOUS GLAND; SEBACEOUS GLAND DISEASE; SEBACEOUS GLAND HYPERPLASIA; SEBACEOUS NEVUS; SKIN CANCER; SKIN LEISHMANIASIS; SKIN PAIN; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SUPPURATIVE HIDRADENITIS; TINEA CORPORIS; TREATMENT INDICATION; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VERRUCA VULGARIS;

AMINOLEVULINIC ACID; HUMANS; PHOTOCHEMOTHERAPY; REJUVENATION; SKIN DISEASES; SKIN NEOPLASMS;

EID: 77952803966     PISSN: 15748871     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488710791233572     Document Type: Article

References (52)

1. Calzavara-Pinton PG, Venturini M, Sala R. Photodynamic therapy: update 2006 Part 2: Clinical results. J Eur Acad Dermatol Venereol 2007; 21: 439-51.
2. Klein A, Babilas P, Karrer S, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology - an update. J Dtsc Dermatol Ges 2008; 6: 839-45.
3. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B Biol 1990; 6: 14348.
4. Ortel B, Shea CR, Calzavara-Pinton PG. Molecular mechanisms of photodynamic therapy. Front Biosci 2009; S1: 320-35.
5. Calzavara-Pinton PG, Venturini M, Sala R, et al. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Br J Dermatol 2008; 159: 137-44.
6. Radakovic-Fijan S, Honigsmann H, Tanew A. Efficacy of topical photodynamic therapy of a giant keratoacanthoma demonstrated by partial irradiation. Br J Dermatol 1999; 141: 936-7.
7. Lee MR, Ryman W. Erytroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy. Aust J Dermatol 2005; 46: 196-8.
8. Paoli J, Bratel TA, Lowhagen GB, Stenquist B, Forslund O, Wennberg AM. Penile intraepithelial neoplasia: results of photodynamic therapy. Acta Dermatol Venereol 2006; 86: 418-21.
9. Axcrona K, Brennhovd B, Alfsen GC, Giercksky KE, Warloe T. Photodynamic therapy with methyl aminolevulinate for atypial carcinoma in situ of the penis. Scand J Urol Nephrol 2007; 41: 507-10.
10. Buechner SA. Common skin disorders of the penis. BJU Int 2002; 90: 498-506.
11. Kanitakis J. Mammary and extramammary Paget's disease. J Eur Acad Dermatol Venereol 2007; 21: 581-90.
12. Shieh S, Dee AS, Cheney RT, Frawley NP, Zeitouni NC, Oseroff AR. Photodynamic therapy for the treatment of extramammary Paget's disease. Br J Dermatol 2002; 146: 1000-5.
13. Zane C, Venturini M, Sala R, Calzavara-Pinton P. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma. Photodermatol Photoimmunol Photomed 2006; 22: 254-58.
14. Zane C, Capezzera R, Sala R, Venturini M, Calzavara-Pinton P. Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin. Lasers Surg Med 2007; 39: 203-9.
15. Touma D, Yaar M, Whitehead S, Konnikov V, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004; 140: 33-40.
16. Goldman MP, Atkin D, Kincad S. PDT/ ALA in the treatment of actinic damage: real world experience. J Lasers Med Surg 2002; 14: S24.
17. Gold MH. Intense pulsed light therapy for photorejuvenation enhanced with 20% aminolevulinic acid photodynamic therapy. J Lasers Med Surg 2003; 15: S47.
18. Gold MH, Goldman MP. 5-Aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatol Surg 2004; 30: 1077-84.
19. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513-9.
20. Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. J Eur Acad Dermatol Venereol 2006; 86: 25-28.
21. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol Venereol 2000; 115: 183-92.
22. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008; 159: 1245-66.
23. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch Dermatol 2000; 136: 1093-5.
24. Uebelhoer NS, Dover J. Photodynamic therapy for cosmetic applications. Dermatol Ther 2005; 18: 242-52.
25. Goldman MP, Boyce S. A single-center study of aminolevulinic acid and 417nm photodynamic therapy in the treatment of moderate to severe acne vulgaris. J Drugs Dermatol 2003; 2: 393-6.
26. Alexiades-Armenakas MR. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild-tosevere comedonal, inflammatory, or cystic acne. J Drugs Dermatol 2006; 5: 45-55.
27. Grossman M, Wimberly J, Dwyer P. PDT for hirsutism. Lasers Surg Med 1995; 87 (Suppl.): 44-51.
28. Horio T, Horio O, Miyauchi-Hashimoto H. Photodynamic therapy of sebaceous hyperplasia with topical 5-aminolevulinic acid and slide projector. Br J Dermatol 2003; 148: 1274-6.
29. Nybaek H, Jemec GB. Photodynamic therapy in the treatment of rosacea. Dermatology 2005; 211: 135-8.
30. Dierickx CC, Goldenhersh M, Dwyer P, Stratigos A, Mihm M, Anderson RR. Photodynamic therapy for nevus sebaceus with topical deltaaminolevulinic acid. Arch Dermatol 1999; 135: 637-40.
31. Gold MH, Bridges TM, Bradshaw VL, Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol 2004; 3: S32-S35.
32. Beattie PE, Dawe RS, Ferguson J, Ibbotson SH. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy. Clin Exp Dermatol 2004; 29: 545-62.
33. Radakovic-Fijan S, Blecha-Thalhammer U, et al. Topical aminolevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol 2005; 152: 279-83.
34. Piaserico S, Zattra E, Linder D, Peserico A. Generalized granuloma annulare treated with methylaminolevulinate photodynamic therapy. Dermatology 2009; 218(3): 282-4.
35. Weisenseel P, Kuznetsov AV, Molin S, Ruzicka T, Berking C, Prinz JC. Photodynamic therapy for granuloma annulare: more than a shot in the dark. Dermatology 2008; 217(4): 329-32.
36. Mikasa K, Watanabe D, Kondo C, Tamada Y, Matsumoto Y. Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma. J Am Acad Dermatol 2005; 53(5): 911-2.
37. Fernandez-Guarino M, Perez-Garcia B, Harto A, Jean PJ. Discoid lupus erythematosus: good response to treatment with photodynamic therapy. Eur Acad Dermatol Venereol 2008; 22(9): 1142-3.
38. Fernandez-Guarino M, Harto A, Jean P. Failure to treat keratoderma in Papillon-Lefevre syndrome using photodynamic therapy. Eur J Dermatol 2007; 17(5): 456-7.
39. Kyung SK, Hyung EK, Chan YK. Treatment of pigmented purpuric dermatosis with topical photodynamic therapy. Dermatology 2009; 219: 184-6.
40. Stender IM, Na R, Fogh H. Photodynamic therapy with 5-aminolevulinic acid or placebo for recalcitrant foot and hand warts: randomized double blind trial. Lancet 2000; 355: 963-96.
41. Stefanaki IM, Georgiou S, Themelis GC, Vazgiouraki EM, Tosca AD. In vivo fluorescence kinetics and photodynamic therapy in condylomata acuminate. Br J Dermatol 2003; 149: 972-6.
42. Moiin A. Photodynamic therapy for molluscum contagiosum infection in HIV-coinfected patients: review of 6 patients. J Drugs Dermatol 2003; 2: 637-9.
43. Stender IM, Borgbjerg FM, Villumsen J, Lock-Andersen J, Wulf HC. Pain induced by photodynamic therapy of warts. Photodermatol Photoimmunol Photomed 2006; 22: 304-9.
44. Enk CD, Fritsch C, Jonas F, et al. Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol 2003; 139: 432-4.
45. Horn M, Wolf P. Topical methyl aminolevulinate photodynamic therapy for the treatment of folliculitis. Photodermatol Photoimmunol Photomed 2007; 23: 145-7.
46. Clayton TH, Harrison PV. Photodynamic therapy for infected leg ulcers. Br J Dermatol 2007; 156: 378-410.
47. Calzavara-Pinton PG, Venturini M, Capezzera R, Sala R, Zane C. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid. Photodermatol Photoimmunol Photomed 2004; 20: 144-7.
48. Donnelly RF, McCarron PA, Lightowler JM, Woolfson AD. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. J Control Release 2005; 103: 381-92.
49. Warren CB, Karai LJ, Vidimos A, Maytin EV. Pain associated with aminolevulinic acid-photodynamic therapy of skin disease. J Am Acad Dermatol 2009; 61: 1033-43.
50. Kasche A, Luderschmidt S, Ring J, Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 2006; 5: 353-6.
51. Moloney FJ, Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 2007; 157: 87-91.
52. Steinbauer JM, Schreml S, Babilas P, et al. Topical photodynamic therapy with porphyrin precursors--assessment of treatmentassociated pain in a retrospective study. Photochem Photobiol Sci 2009; 8: 1111-6.